Max Healthcare Institute's NCLT case on Kalinga Hospital moves to 30 Oct

Legal
Hospitals

Blacklitt Research29 October 20262 min read

An empty hospital corridor with a beige floor, white walls, a red stripe along the wall and ceiling lights receding into the distance. — W.carter, via Wikimedia Commons (CC0). Illustrative image.

Max Healthcare Institute (NSE: MAXHEALTH) said in a filing on 29 Oct 2026 that petitions against its subsidiary Kalinga Hospital Ltd. (KHL) before the National Company Law Tribunal (NCLT), Cuttack Bench, could not be heard on the day they were listed. The NCLT adjourned the matter to 30 Oct 2026 for further hearing.

Petitions filed by BRS Capital Two Pte. Limited's legal representatives

The petitions, including interlocutory petitions, were filed before the NCLT Cuttack Bench by the legal representatives of BRS Capital Two Pte. Limited against KHL. BRS Capital Two is described as the other shareholder of KHL, from whom the company acquired the majority equity stake.

The company had first informed the exchanges about these petitions in an earlier intimation dated 29 Sep 2026.

Hearing not taken up on 29 Oct 2026

The matter was listed for hearing on 29 Oct 2026 at 2.30 pm IST. The company says the matter could not be heard that day due to paucity of time.

The NCLT adjourned the matter to 30 Oct 2026 for further hearing, and the filing does not say what the bench will take up on that date.

What the adjournment means for Max Healthcare Institute's shareholders

The hearing did not take place on the listed date, and the case now comes up on 30 Oct 2026. Relief sought in the petitions, amounts claimed, and any effect on the company or KHL are not stated. The outcome of the 30 Oct 2026 hearing is not stated.

At a glance

Item	Detail
Subsidiary in the case	Kalinga Hospital Ltd. (KHL)
Forum	National Company Law Tribunal, Cuttack Bench
Earlier intimation	29 Sep 2026
Listed for hearing	29 Oct 2026, 2.30 pm IST
Adjourned to	30 Oct 2026

Reference: Original filing (PDF)

Sign up to continue reading

Create a free account to read the rest of this article and the analysis that follows.

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.